Evidence map›Paper›PMID 17553894›Full record

ArticleJournal of virology2007

Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction.

Diana M Brainard, Andrew M Tager, Joseph Misdraji, Nicole Frahm, Mathias Lichterfeld, Rika Draenert, Christian Brander, Bruce D Walker, Andrew D Luster

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Cytolytic CD8Science immunology · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. CXCR3 in T cell function.Experimental cell research · 2011
    Article
  17. Review
  18. Host genes associated with HIV-1 replication in lymphatic tissue.Journal of immunology (Baltimore, Md. : 1950) · 2010
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Diana M BrainardMassachusetts General Hospital, Building 149, 13th Street, Charlestown, MA 02129, USA.
Andrew M Tager
Joseph Misdraji
Nicole Frahm
Mathias Lichterfeld
Rika Draenert
Christian Brander
Bruce D Walker
Andrew D Luster
Massachusetts General Hospital · USHarvard University · USLudwig-Maximilians-Universität München · DE

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
IP 10--ITS ROLE IN INFLAMMATION AND CANCER THERAPYR01CA069212 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LUSTER, ANDREW D · 1996 to 2014
$5.6M
The effects of HIV gp120 on CTL migration and efficacyK08AI058857 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BRAINARD, DIANA M · 2004 to 2006
$316k
NCI NIH HHS R01 CA069212NCI NIH HHS R01 CA 69212NIAID NIH HHS K08 AI 058857NIAID NIH HHS K08 AI058857NIAID NIH HHS P30 AI060354
6 · The paper itself

Abstract

To exert their cytotoxic function, cytotoxic T-lymphocytes (CTL) must be recruited into infected lymphoid tissue where the majority of human immunodeficiency virus (HIV) replication occurs. Normally, effector T cells exit lymph nodes (LNs) and home to peripheral sites of infection. How HIV-specific CTL migrate into lymphoid tissue from which they are normally excluded is unknown. We investigated which chemokines and receptors mediate this reverse homing and whether impairment of this homing could contribute to CTL dysfunction as HIV infection progresses. Analysis of CTL chemokine receptor expression in the blood and LNs of untreated HIV-infected individuals with stable, chronic infection or advanced disease demonstrated that LNs were enriched for CXCR3(+) CD8 T cells in all subjects, suggesting a key role for this receptor in CTL homing to infected lymphoid tissue. Compared to subjects with chronic infection, however, subjects with advanced disease had fewer CXCR3(+) CD8 T cells in blood and LNs. CXCR3 expression on bulk and HIV-specific CD8 T cells correlated positively with CD4 count and negatively with viral load. In advanced infection, there was an accumulation of HIV-specific CD8 T cells at the effector memory stage; however, decreased numbers of CXCR3(+) CD8 T cells were seen across all maturation subsets. Plasma CXCL9 and CXCL10 were elevated in both infected groups in comparison to the levels in uninfected controls, whereas lower mRNA levels of CXCR3 ligands and CD8 in LNs were seen in advanced infection. These data suggest that both CXCR3(+) CD8 T cells and LN CXCR3 ligands decrease as HIV infection progresses, resulting in reduced homing of CTL into LNs and contributing to immune dysfunction.

Indexed as

Chemotaxis, LeukocyteAmino Acid SequenceCD4 Lymphocyte CountCD4-Positive T-LymphocytesCD8 AntigensCytokinesHIV InfectionsHumansLigandsLymph NodesMolecular Sequence DataReceptors, ChemokineReceptors, CXCR3RNA, MessengerT-Lymphocytes, CytotoxicViral LoadCD8 AntigensCXCR3 protein, humanCytokinesLigandsReceptors, ChemokineReceptors, CXCR3RNA, Messenger

Identifiers

PMID17553894
PMCPMC1951383
OpenAlexW2118321819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.